PIAS2
Basic information
Region (hg38): 18:46803218-46920160
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PIAS2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 31 | 32 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 31 | 0 | 2 |
Variants in PIAS2
This is a list of pathogenic ClinVar variants found in the PIAS2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
18-46812438-C-T | not specified | Uncertain significance (Jun 28, 2022) | ||
18-46812474-T-C | not specified | Uncertain significance (Dec 21, 2023) | ||
18-46812480-T-C | Benign (Oct 23, 2018) | |||
18-46812493-A-T | not specified | Uncertain significance (Jan 22, 2024) | ||
18-46812532-A-T | not specified | Uncertain significance (Apr 09, 2024) | ||
18-46812548-G-A | not specified | Uncertain significance (Nov 27, 2024) | ||
18-46812564-T-C | not specified | Uncertain significance (Dec 10, 2024) | ||
18-46812590-T-C | not specified | Uncertain significance (Dec 28, 2023) | ||
18-46820951-T-C | not specified | Uncertain significance (Apr 07, 2023) | ||
18-46820986-T-C | not specified | Uncertain significance (Jan 29, 2025) | ||
18-46821008-T-C | not specified | Uncertain significance (Apr 26, 2023) | ||
18-46821008-T-G | not specified | Uncertain significance (Jan 23, 2024) | ||
18-46821017-G-T | not specified | Uncertain significance (Mar 02, 2023) | ||
18-46821063-C-T | not specified | Uncertain significance (Jun 30, 2022) | ||
18-46828046-A-G | not specified | Uncertain significance (Jul 27, 2022) | ||
18-46828122-C-T | not specified | Uncertain significance (Sep 22, 2022) | ||
18-46829757-C-G | not specified | Uncertain significance (Nov 10, 2024) | ||
18-46836358-C-T | not specified | Uncertain significance (Dec 16, 2022) | ||
18-46844764-T-C | not specified | Uncertain significance (Aug 12, 2021) | ||
18-46846783-T-C | not specified | Uncertain significance (Mar 28, 2024) | ||
18-46855381-T-C | Benign (Mar 29, 2018) | |||
18-46864208-A-C | not specified | Uncertain significance (May 30, 2023) | ||
18-46890619-A-G | not specified | Uncertain significance (Jul 25, 2023) | ||
18-46890628-G-T | not specified | Uncertain significance (Sep 22, 2022) | ||
18-46890630-T-C | not specified | Uncertain significance (Dec 27, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PIAS2 | protein_coding | protein_coding | ENST00000585916 | 14 | 111771 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.997 | 0.00282 | 125740 | 0 | 6 | 125746 | 0.0000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.06 | 226 | 331 | 0.682 | 0.0000168 | 4045 |
Missense in Polyphen | 16 | 38.264 | 0.41815 | 488 | ||
Synonymous | 0.947 | 107 | 120 | 0.890 | 0.00000637 | 1212 |
Loss of Function | 4.61 | 3 | 30.5 | 0.0984 | 0.00000164 | 392 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000152 | 0.000152 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000884 | 0.00000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000655 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Functions as an E3-type small ubiquitin-like modifier (SUMO) ligase, stabilizing the interaction between UBE2I and the substrate, and as a SUMO-tethering factor. Plays a crucial role as a transcriptional coregulator in various cellular pathways, including the STAT pathway, the p53 pathway and the steroid hormone signaling pathway. The effects of this transcriptional coregulation, transactivation or silencing may vary depending upon the biological context and the PIAS2 isoform studied. However, it seems to be mostly involved in gene silencing. Binds to sumoylated ELK1 and enhances its transcriptional activity by preventing recruitment of HDAC2 by ELK1, thus reversing SUMO-mediated repression of ELK1 transactivation activity. Isoform PIAS2-beta, but not isoform PIAS2-alpha, promotes MDM2 sumoylation. Isoform PIAS2-alpha promotes PARK7 sumoylation. Isoform PIAS2-beta promotes NCOA2 sumoylation more efficiently than isoform PIAS2- alpha. Isoform PIAS2-alpha sumoylates PML at'Lys-65' and 'Lys- 160'. {ECO:0000269|PubMed:15920481, ECO:0000269|PubMed:15976810, ECO:0000269|PubMed:22406621}.;
- Pathway
- Jak-STAT signaling pathway - Homo sapiens (human);Ubiquitin mediated proteolysis - Homo sapiens (human);JAK-STAT-Ncore;Androgen receptor signaling pathway;TGF-beta Signaling Pathway;sumoylation by ranbp2 regulates transcriptional repression;SUMOylation of DNA damage response and repair proteins;SUMOylation of transcription factors;IL12 signaling mediated by STAT4;SUMOylation of chromatin organization proteins;Post-translational protein modification;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;SUMOylation;Sumoylation by RanBP2 regulates transcriptional repression
(Consensus)
Recessive Scores
- pRec
- 0.287
Intolerance Scores
- loftool
- 0.184
- rvis_EVS
- -0.43
- rvis_percentile_EVS
- 25.37
Haploinsufficiency Scores
- pHI
- 0.982
- hipred
- Y
- hipred_score
- 0.748
- ghis
- 0.578
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.993
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pias2
- Phenotype
- skeleton phenotype; limbs/digits/tail phenotype; hearing/vestibular/ear phenotype; vision/eye phenotype; reproductive system phenotype; pigmentation phenotype; cellular phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- protein sumoylation;androgen receptor signaling pathway;positive regulation of transcription, DNA-templated;negative regulation of androgen receptor signaling pathway
- Cellular component
- nucleus;nucleoplasm;PML body;nuclear speck
- Molecular function
- DNA binding;transcription coactivator activity;protein binding;transcription factor binding;zinc ion binding;SUMO transferase activity;ubiquitin protein ligase binding;androgen receptor binding;SUMO ligase activity